2HEL | A: | CRYSTAL STRUCTURE OF A MUTANT EPHA4 KINASE DOMAIN (Y742A) |
2HEN | A:; B:; C:; D: | CRYSTAL STRUCTURE OF THE EPHB2 RECEPTOR KINASE DOMAIN IN COMPLEX WITH ADP |
2QOH | A:; B: | CRYSTAL STRUCTURE OF ABL KINASE BOUND WITH PPY-A |
2XYU | A: | CRYSTAL STRUCTURE OF EPHA4 KINASE DOMAIN IN COMPLEX WITH VUF 12058 |
2Y6M | A: | CRYSTAL STRUCTURE OF EPHA4 KINASE DOMAIN |
2Y6O | A: | CRYSTAL STRUCTURE OF EPHA4 KINASE DOMAIN IN COMPLEX WITH DASATINIB. |
2YA9 | A:; B: | CRYSTAL STRUCTURE OF THE AUTOINHIBITED FORM OF MOUSE DAPK2 |
2YAA | A:; B: | CRYSTAL STRUCTURE OF THE AUTOINHIBITED FORM OF MOUSE DAPK2 IN COMPLEX WITH ATP |
2YAB | A:; B: | CRYSTAL STRUCTURE OF THE AUTOINHIBITED FORM OF MOUSE DAPK2 IN COMPLEX WITH AMP |
2Z60 | A: | CRYSTAL STRUCTURE OF THE T315I MUTANT OF ABL KINASE BOUND WITH PPY-A |
3D14 | A: | CRYSTAL STRUCTURE OF MOUSE AURORA A (ASN186->GLY, LYS240->ARG, MET302->LEU) IN COMPLEX WITH 1-{5-[2-(THIENO[3,2-D]PYRIMIDIN-4-YLAMINO)-ETHYL]- THIAZOL-2-YL}-3-(3-TRIFLUOROMETHYL-PHENYL)-UREA |
3D15 | A: | CRYSTAL STRUCTURE OF MOUSE AURORA A (ASN186->GLY, LYS240->ARG, MET302->LEU) IN COMPLEX WITH 1-(3-CHLORO-PHENYL)-3-{5-[2-(THIENO[3,2-D]PYRIMIDIN-4-YLAMINO)- ETHYL]-THIAZOL-2-YL}-UREA [SNS-314] |
3D2I | A: | CRYSTAL STRUCTURE OF MOUSE AURORA A (ASN186->GLY, LYS240->ARG, MET302->LEU) IN COMPLEX WITH 1-{5-[2-(1-METHYL-1H-PYRAZOLO[4,3-D]PYRIMIDIN-7-YLAMINO)-ETHYL]-THIAZOL-2-YL}-3-(3-TRIFLUOROMETHYL-PHENYL)-UREA |
3D2K | A: | CRYSTAL STRUCTURE OF MOUSE AURORA A (ASN186->GLY, LYS240->ARG, MET302->LEU) IN COMPLEX WITH [7-(2-{2-[3-(3-CHLORO-PHENYL)-UREIDO]-THIAZOL-5-YL}-ETHYLAMINO)-PYRAZOLO[4,3-D]PYRIMIDIN-1-YL]-ACETIC ACID |
3DAJ | A: | CRYSTAL STRUCTURE OF AURORA A COMPLEXED WITH AN INHIBITOR DISCOVERED THROUGH SITE-DIRECTED DYNAMIC TETHERING |
3DJ5 | A: | CRYSTAL STRUCTURE OF THE MOUSE AURORA-A CATALYTIC DOMAIN (ASN186->GLY, LYS240->ARG, MET302->LEU) IN COMPLEX WITH COMPOUND 290. |
3DJ6 | A: | CRYSTAL STRUCTURE OF THE MOUSE AURORA-A CATALYTIC DOMAIN (ASN186->GLY, LYS240->ARG, MET302->LEU) IN COMPLEX WITH COMPOUND 823. |
3DJ7 | A: | CRYSTAL STRUCTURE OF THE MOUSE AURORA-A CATALYTIC DOMAIN (ASN186->GLY, LYS240->ARG, MET302->LEU) IN COMPLEX WITH COMPOUND 130. |
3DK3 | A:; B: | CRYSTAL STRUCTURE OF MUTANT ABL KINASE DOMAIN IN COMPLEX WITH SMALL MOLECULE FRAGMENT |
3DK6 | A:; B: | CRYSTAL STRUCTURE OF MUTANT ABL KINASE DOMAIN IN COMPLEX WITH SMALL MOLECULE FRAGMENT |
3DK7 | A:; B: | CRYSTAL STRUCTURE OF MUTANT ABL KINASE DOMAIN IN COMPLEX WITH SMALL MOLECULE FRAGMENT |
3IDB | A: | CRYSTAL STRUCTURE OF (108-268)RIIB:C HOLOENZYME OF CAMP-DEPENDENT PROTEIN KINASE |
3IDC | A: | CRYSTAL STRUCTURE OF (102-265)RIIB:C HOLOENZYME OF CAMP-DEPENDENT PROTEIN KINASE |
3IK3 | A:; B: | AP24534, A PAN-BCR-ABL INHIBITOR FOR CHRONIC MYELOID LEUKEMIA, POTENTLY INHIBITS THE T315I MUTANT AND OVERCOMES MUTATION-BASED RESISTANCE |
3K5V | A:; B: | STRUCTURE OF ABL KINASE IN COMPLEX WITH IMATINIB AND GNF-2 |
3KF4 | A:; B: | STRUCTURAL ANALYSIS OF DFG-IN AND DFG-OUT DUAL SRC-ABL INHIBITORS SHARING A COMMON VINYL PURINE TEMPLATE |
3KFA | A:; B: | STRUCTURAL ANALYSIS OF DFG-IN AND DFG-OUT DUAL SRC-ABL INHIBITORS SHARING A COMMON VINYL PURINE TEMPLATE |
3MS9 | A:; B: | ABL KINASE IN COMPLEX WITH IMATINIB AND A FRAGMENT (FRAG1) IN THE MYRISTATE POCKET |
3MSS | A:; B:; C:; D: | ABL KINASE IN COMPLEX WITH IMATINIB AND FRAGMENT (FRAG2) IN THE MYRISTATE SITE |
3O7L | B:; D: | CRYSTAL STRUCTURE OF PHOSPHOLAMBAN (1-19):PKA C-SUBUNIT:AMP-PNP:MG2+ COMPLEX |
3OXZ | A: | CRYSTAL STRUCTURE OF ABL KINASE DOMAIN BOUND WITH A DFG-OUT INHIBITOR AP24534 |
3OY3 | A:; B: | CRYSTAL STRUCTURE OF ABL T315I MUTANT KINASE DOMAIN BOUND WITH A DFG-OUT INHIBITOR AP24589 |
3TNP | C:; F: | STRUCTURE AND ALLOSTERY OF THE PKA RIIB TETRAMERIC HOLOENZYME |